Observational studyCancer research and treatment2023

Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy.

Sang Joon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.